Continuity Biosciences
UEI: KTR8EE8DBFX5
• CAGE: 13F55
Overview
Awardee Type
Parent
Company Description
Continuity BiosciencesEnabling Breakthrough Therapieswith Novel Delivery Technologies Convergence of biopharmaceuticals, drug delivery approaches, and medical technologies is realizing therapies that are not possible through any of these fields individually – products that benefit from this convergence are called combination products.Robert Whitehead, Alessandro Grattoni and Ramakrishna Venugopalan founded Continuity Biosciences in 2024 with the aspiration of
Name
Continuity Biosciences
Headquarters
Bradenton, FL
United States
United States
Most Recent Award
Sept. 5, 2025
Calculating
Federal contract recipient
CONTINUITY BIOSCIENCES, LLC
(UEI KTR8EE8DBFX5, CAGE 13F55)
is headquartered in Bradenton FL.
Its primary registered NAICS is 339112 Surgical and Medical Instrument Manufacturing.
The partnership
was founded in November 2023 and
federally registered in
March 2025.
Federal Award Analysis
Continuity Biosciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CONTINUITY BIOSCIENCES, LLC
UEI
KTR8EE8DBFX5
CAGE Code
13F55
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Nov. 27, 2023
Initial Registration
March 3, 2025
Last Registration
June 23, 2025
Registration Activation
June 23, 2025
Registration Expiration
June 19, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
DE
Country of Incorporation
USA
Reported NAICS
Accepts Credit Cards
No